• Product NameBendroflumethiazide
• Brief DescriptionInhibitors
• Purification99.94%
• Biological ActivityA thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
• Target NameCarbonic Anhydrase inhibitor; Potassium Channel
• CAS No. 73-48-3
• Calculated MW 421.41
• Formulation C15H14F3N3O4S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
  Pathways:Membrane transporter/Ion channel; Metabolism
  Receptor:Carbonic anhydrase; Potassium Channel
  Boling pt:
  Melting pt:205-207C
  Solubility:soluble in Water
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Tricarico D, et al. FASEB J. 2004 Apr;18(6):760-1.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting